NUVASIVE POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID5272711924

KRS0000502519

Share capital5,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. PUŁAWSKA 2, 02-566 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

NUVASIVE POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. PUŁAWSKA 2, 02-566 WARSZAWA

Show on map

NIP

5272711924

REGON

147165951

KRS

0000502519

Legal form

limited liability company

Register Address

UL. PUŁAWSKA 2, 02-566 WARSZAWA

Date of registration in KRS

2014-03-20

Date of commencement of economic activity

2014-03-20

Act signature

RDF/717500/25/391

Pkd codes

46.46.Z - Wholesale trade of pharmaceutical and medical products

21.10.Z - Manufacture of basic pharmaceutical products

21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products

25.99.Z - Manufacture of other ready-made metal products not elsewhere classified

26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment

46.18.Z - Activity of agents involved in wholesale trade of other specified goods

46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods

46.64.Z - Wholesale trade of other machines and devices

46.86.Z - Wholesale trade of other semi-finished products

46.90.Z - Non-specialized wholesale trade

Payer VAT status

Active

Vat list bank account(s)

PL97 1020 1013 0000 0102 0309 7060

Company authorities

representation authorityMANAGEMENT

representation type

SPÓŁKA JEST REPREZENTOWANA PRZEZ KAŻDEGO CZŁONKA ZARZĄDU DZIAŁAJĄCEGO SAMODZIELNIE.

MANAGEMENT

Keith William Pfeil

Member Of The Board

Dustin Shields

Member Of The Board

shareholders

NUVASIVE NETHERLANDS B.V.

100% 100 udziałów o łącznej wartości 5000,00 zł

proxies

Michał Nosowski

spontaneous prokura, 41 years old

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Gross profit (loss)	0,2	0,3	0,7	151
EBITDA	1	0,9	0,3	-70
Short time liabilities	2,6	6	11,1	86,6
Equity capital	-0,6	-0,3	0,3	193,7
Operating profit (EBIT)	1	0,9	0,3	-70
Assets	3,5	7,3	11,8	61,7
Net profit (loss)	0,2	0,3	0,7	133,4
Cash	1,9	4,6	6,4	38,5
Net income from sale	7,8	10,8	18,1	67,4
Liabilities and provisions for liabilities	4,1	7,6	11,5	50,2
Working assets	3,5	7,3	11,8	61,7
Depreciation	0	0	0	0
	%	%	%	p.p.
Profitability of capital	-29	-83	206,8	289,8
Equity capital to total assets	-17,9	-4,7	2,7	7,4
Gross profit margin	2,6	2,8	4,1	1,3
EBITDA Margin	12,4	8,5	1,5	-7
	Days	Days	Days	Days
Short term commitment turnover cycle	121	202	225	23

Current financial liquidity indicator	1.287306785583496	1.1991450786590576	1.0278651714324951	-0,2
Net dept to EBITDA	-0.5177116990089417	-3.3622307777404785	-14.574416160583496	-11,2